Answers are grounded in this paper and cite their sources.
Background: International guidelines are increasingly advocating for sentinel lymph node (SLN) omission in early breast cancer patients over 70 years. Studies examining such omission in patients with more aggressive phenotypes [lobular subtype/grade 3/lymphovascular invasion (LVI)] are lacking. The aim was to assess the rate of nodal positivity in these subgroups.
No takes yet. Share an insight, caveat, or question.
Agha et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: